1-3 of 3
Birgit Ackermann
Close
Sort by
Journal Articles

High expression of CD40 on B-cell precursor acute lymphoblastic leukemia blasts is an independent risk factor associated with improved survival and enhanced capacity to up-regulate the death receptor CD95

Clinical Trials & Observations
Anja Troeger, Ludmila Glouchkova, Birgit Ackermann, Gabriele Escherich, Roland Meisel, Helmut Hanenberg, Monique L. den Boer, Rob Pieters, Gritta E. Janka-Schaub, Ulrich Goebel, Hans-Juergen Laws, Dagmar Dilloo
Journal: Blood
Blood (2008) 112 (4): 1028–1034.
https://doi.org/10.1182/blood-2007-11-123315
Published: 2008
Journal Articles

Increased TNF/NGF Receptor Expression on BCP-ALL Blasts Carrying the Prognostically Favorable TEL-AML Rearrangement.

Anja Troeger, MD, Ludmila Glouchkova, PhD, Birgit Ackermann, PhD, Gabriele Escherich, MD, Roland Meisel, MD, Hans-Juergen Laws, MD, Helmut Hanenberg, MD, Silja Roettgers, PhD, Gritta Janka-Schaub, MD, Arndt Borkhardt, MD, Ulrich Goebel, MD, Dagmar Dilloo, MD
Journal: Blood
Blood (2007) 110 (11): 1431.
https://doi.org/10.1182/blood.V110.11.1431.1431
Published: 2007
Journal Articles

High Expression of CD40 on BCP-ALL Blasts Is an Independent Risk Factor Associated with Improved Survival and Enhanced Capacity To Upregulate the Death Receptor CD95.

Anja Troeger, MD, Ludmila Glouchkova, PhD, Birgit Ackermann, PhD, Gabriele Escherich, MD, Roland Meisel, MD, Helmut Hanenberg, MD, Gritta Janka, MD, Ulrich Goebel, MD, Hans-Juergen Laws, MD, Dagmar Dilloo, MD
Journal: Blood
Blood (2006) 108 (11): 2282.
https://doi.org/10.1182/blood.V108.11.2282.2282
Published: 2006